OriGene Technologies, Inc.
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Tissue Other Products Tech Support
orange


OriGene shRNA in recent publications
Enhancement of Autophagy during Lytic Replication by the Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription Activator J. Virol., Aug 2010; 84: 7448 - 7458 [BECN1]

Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53 Mol. Cell. Biol., Aug 2010; 30: 3981 - 3993 [MYB ]

GPR103b Functions in the Peripheral Regulation of Adipogenesis Mol. Endocrinol., Aug 2010; 24: 1615 - 1625 []

Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis J. Biol. Chem., Aug 2010; 285: 24707 - 24716 [pRS]

ADSL (Locus ID 158) Human shRNA

divider

To view the shRNA sequence, please register your email:
Email:
Register To View
Specifications Related Products Product Manual FAQs
Catalog No. Description Vector Price Delivery
TF314909 HuSH 29mer shRNA Constructs against ADSL in pRFP-C-RS vector (Locus ID = 158)
4 constructs, 5 µg purified plasmid DNA per construct.
pRFP-C-RS $ 650 7-9 Days *
TR30014 HuSH shRNA RFP cloning vector (pRFP-C-RS) Included for free
TR30015 Non-effective 29-mer scrambled shRNA cassette in pRFP-C-RS Vector Included for free
Add to Shopping Cart
* Delivery time in business days.
* These shRNA constructs were designed to be effective against maximum number of transcriptional variants at this gene locus.

Also for ADSL (Locus ID 158)
spacer
Register To View Sequence

Reference Data
RefSeq: NM_000026NM_001123378
Synonyms: AMPS; ASASE; ASL
Summary: Adenylsuccinate lyase is involved in both de novo synthesis of purines and formation of adenosine monophosphate from inosine monophosphate. It catalyzes two reactions in AMP biosynthesis: the removal of a fumarate from succinylaminoimidazole carboxamide (SAICA) ribotide to give aminoimidazole carboxamide ribotide (AICA) and removal of fumarate from adenylosuccinate to give AMP. Adenylosuccinase deficiency results in succinylpurinemic autism, psychomotor retardation, and , in some cases, growth retardation associated with muscle wasting and epilepsy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq].
Performance Guranteed:
OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.

For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

 

pattern
Copyright © 2010 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436


Reproduction of any materials from this website is strictly forbidden without permission.